The Stryker Rejuvenate Modular Hip device has been linked to a high early failure rate resulting in revision surgeries for many patients.
Announcement: Billion-Dollar Global Settlement
On November 3, 2014, a global settlement program involving Stryker’s Rejuvenate and ABGII modular hip implants was executed before and announced by Superior Court Judge Brian R. Martinotti in Bergen County, New Jersey. Settlement payments are expected to exceed $1 billion, available to more than 4,000 eligible known claimants nationwide. Claimants could begin receiving their awards in the summer of 2015 The Full Story
The Rejuvenate Hip is different from other hip replacement devices because it is not a typical metal-on-metal hip replacement. Instead, the Rejuvenate uses a ceramic component in association with a metal component that is custom-made in an effort to fit patients better. Originally, the Rejuvenate was projected to be able to last for 15 to 20 years, but many are failing in under just five years.
The failures are due primarily to patients’ development of “metallosis,” or metal poisoning, which is an adverse tissue reaction caused by a buildup of heavy metals in the body. The Rejuvenate Hip has been voluntarily recalled by its manufacturer, Stryker, due to the risk for metallosis cause by fretting and corrosion. Metallosis can lead to:
- Pain/Inflammatory reaction
- Breakdown of muscles and tendons
- Dissolution of the bone
- Chromosomal Aberrations
- Loss of surrounding bone
If you or a loved one has suffered complications as a result of a Stryker Rejuvenate Hip replacement, you should immediately contact the attorneys at Pogust Braslow & Millrood, where Protecting Consumers Is Our Primary Goal.